OP0104 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis Including Current Skin Involvement: Results of a Phase 3, Randomized, Controlled Trial

C. Birbara, Francisco J. Blanco, Jeffrey Crowley, C. Hu, R. Stevens, C. J. Edwards

Annals of the Rheumatic Diseases · 2013 · 15 citations · 0 references

Concepts